- امروز : چهارشنبه, ۲۸ آذر , ۱۴۰۳
- برابر با : Wednesday - 18 December - 2024
اخبار ویژه
Silent Damage First: Alzheimer’s Disease Could Have Two Phases
Sports Concussion Outcomes Can Be Made Worse By Depression
Dad’s Use of Diabetes Med Metformin Won’t Raise Birth Defect Risk
Fitness, Activity Boosts Kids’ Mental Health, Too
Exercise in Pregnancy Might Lower Baby’s Odds for Asthma Later
Some IUDs May Raise The Odds for Breast Cancer, But Overall Risk Remains Low
Music Might Speed Your Recovery From Surgery
A Cancer Diagnosis Takes Devastating Toll on Family Finances
Weight Loss
Stomach Paralysis Risk May Rise in People Taking Ozempic and Similar Drugs
New, real-world research confirms that the blockbuster weight-loss drugs that millions of Americans have been taking to shed pounds can trigger stomach paralysis in some patients.
One in 8 U.S. Adults Have Now Used Blockbuster Meds Like Ozempic
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
Stomach-Zapping Procedure Lowers Appetite to Help With Weight Loss
An experimental procedure could reduce levels of a hunger-triggering hormone by burning part of a person’s stomach lining, a new study reports.
Motivational Interviewing Not Better in Weight Loss Programs
Evidence lacking that MI makes meaningful difference to weight loss, well-being when added to behavioral weight management program.
